Skip to main content

Table 1 Clinical characteristics of patients with urothelial carcinomas of the bladder in TCGA

From: MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder

Characteristic

Total

Percentage (%)

n

414

 

Age

 ≤ 70

234

56.5

 > 70

180

43.5

Gender

 Female

109

26.3

 Male

305

73.7

Race

 White

330

83.1

 Asian

44

11.1

 Black or African American

23

5.8

BMI

 ≤ 25

153

42.0

 > 25

211

58.0

Tumor subtype

 Papillary

275

67.2

 Non-papillary

134

32.8

Smoker

 No

109

27.2

 Yes

292

72.8

T stage

 T1

5

1.3

 T2

119

31.3

 T3

196

51.6

 T4

60

15.8

N stage

 N0

239

64.6

 N1, N2, N3

131

35.4

M stage

 M0

202

94.8

 M1

11

5.2

Histologic grade

 Low grade

21

5.1

 High grade

390

94.9

Pathologic stage

 Stage I

4

1.0

 Stage II

130

31.6

 Stage III

142

34.5

 Stage IV

136

33.0